Literature DB >> 11839379

The effect of chemical blockade of PKC with Gö6976 and Gö6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cells.

Ianko Iankov1, Maria Praskova, Silvia Kalenderova, Zvetanka Tencheva, Ivan Mitov, Vanio Mitev.   

Abstract

Interleukin-6 (IL-6) mediates growth of murine B9 hybridoma/plasmacytoma cells via Ras-dependent mitogen-activated protein kinase (MAPK) pathway. Preincubation of cells with selective protein kinase C (PKC) inhibitors Gö6976 and Gö6983 leads to enhancement of IL-6-induced p44/p42 MAPK activity. The basal p44/p42 MAPK activity is also stimulated in the presence of both inhibitors. On the other hand, Gö6976 completely blocks proliferation, but Gö6983 which does not inhibit PKC(mu) has no effect on the cell growth. These findings suggest that PKC(mu) is required for proliferation and other PKC isoenzymes are involved in regulation of IL-6-dependent growth of B9 cells by negative regulation of the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839379     DOI: 10.1016/s0145-2126(01)00132-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

Review 1.  Concise Review: Lessons from Naïve Human Pluripotent Cells.

Authors:  Carol B Ware
Journal:  Stem Cells       Date:  2016-11-10       Impact factor: 6.277

2.  Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.

Authors:  Kanako Izumi-Nagai; Norihiro Nagai; Yoko Ozawa; Masahiko Mihara; Yoshiyuki Ohsugi; Toshihide Kurihara; Takashi Koto; Shingo Satofuka; Makoto Inoue; Kazuo Tsubota; Hideyuki Okano; Yuichi Oike; Susumu Ishida
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

3.  Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions.

Authors:  Nupur Raychaudhuri; Roshini Fernando; Terry J Smith
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.